Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

[A]

Addiction and Substance Abuse (Vol XI, No 1)

For Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings refer to: http://media.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/index.aspx?from=carousel&position=1&date=09052013

For information on alcohol and drug use in adolescents refer to http://www.cdc.gov/HealthyYouth/alcoholdrug/index.htm

For patient information and infographic on secondhand smoke from the Centers for Disease Control and Prevention refer to http://www.cdc.gov/vitalsigns/tobacco/index.html

For information on opioid prescription claims among women of reproductive age-United States, 2008-2012 refer to http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6402a1.htm?s_cid=mm6402a1_w

For FDA Drug Safety Communication regarding pain medicine use in pregnancy refer to http://www.fda.gov/Drugs/DrugSafety/ucm429117.htm

For additional information to assist physicians, refer to the following College resources:

For additional information on marijuana use during pregnancy and lactation go to Marijuana use during pregnancy and lactation. Committee Opinion No. 637. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:234-8.

For a resource from the CDC on alcohol, refer to Tan CH, Denny CH, Cheal NE, Sniezek JE, Kanny D. Alcohol use and binge drinking among women of childbearing age-United States, 2011-2013. MMWR Morb Mortal Wkly Rep 2015;64:1042-6.

For a survey on drug use and health from SAHMSA, refer to Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health

For information on cigarette smoking trends among U.S. adults in 2005-2014, refer to http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6444a2.htm?s_cid=mm6444a2_x

For the latest statistics from the Centers for Disease Control and Prevention regarding smoking cessation during pregnancy, refer to http://www.cdc.gov/mmwr/volumes/65/wr/mm6522a6.htm?s_cid=mm6522a6_x

For statistics from the Centers for Disease Control and Prevention regarding electronic cigarette use in working adults, refer to http://www.cdc.gov/mmwr/volumes/65/wr/mm6522a1.htm?s_cid=mm6522a1_x

Adverse Drug Reactions (Vol XIII, No 4)

For clinical guidelines regarding thrombocytopenia in pregnancy, refer to Thrombocytopenia in pregnancy. Practice Bulletin No. 166. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e43-53.

For recommendations on statin use for the prevention of cardiovascular disease, refer to Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. U.S. Preventive Services Task Force. JAMA 2016;316:1997-2007.

Anemia (Vol XI, No 5)

For additional information on patients who refuse blood transfusion, refer to the following documents:

Gupta S, Onwude J, Stasi R, Manyonda I. Refusal of blood transfusion by Jehovah's Witness women: a survey of current management in obstetric and gynaecological practice in the UK. Blood Transfus 2012;10:462-70.

Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet 2013;381:1855-65.

Anorectal Disorders (Vol IX, No 1)

Anorectal Disorders, Supplement, Volume IX, Number 1, January 2010 (Reaffirmed 2016)

For clinical guidelines on the management of benign anorectal disorders from the American College of Gastroenterology, refer to Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG Clinical Guideline: management of benign anorectal disorders. Am J Gastroenterol 2014;109:1141-57.

Autoimmune Disorders (Vol XIII, No 1)

For clinical guidelines regarding thrombocytopenia in pregnancy, refer to Thrombocytopenia in pregnancy. Practice Bulletin No. 166. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e43-53.

[B]

Benign Breast Disease (Vol XIV, No 3)

For information on hereditary cancer syndromes, refer to Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1538-43.

For recommendations regarding benign breast disease, refer to Diagnosis and management of benign breast disorders. Practice Bulletin No. 164. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e141-56.

[C]

Care of Aging Women (Vol VIII, No 4)

For information on pap test and mammography guidelines refer to: http://www.acog.org/About_ACOG/ACOG_Departments/Annual_Womens_Health_Care/
Your_Annual_Health_Care_Visit

For a resource from the Joint Commission on falls, refer to Sentinel Event Alert 55: Preventing Falls and Fall-Related Injuries in Health Care Facilities

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

Complementary and Alternative Medicine (Vol X, No 4)

For basic information about specific herbs or botanicals refer to: http://nccam.nih.gov/health/herbsataglance.htm

Continuing Care for Women With Breast Cancer (Vol IX, No 2)

For further information on breast cancer refer to the following:

Recommendations for target populations for hereditary breast cancer screening
http://www.nccn.org

BI-RADS - mammography
http://www.acr.org/Quality-Safety/Resources/BIRADS/Mammography

Treatment for late-stage breast cancer
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340704.htm

For patient information from the National Cancer Institute, refer to http://www.cancer.gov/types/breast/patient/breast-treatment-pdq - section/all

For a 2015 review of American Cancer Society guidelines and current issues in cancer screening refer to Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, et al. Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2015;65:30-54.

For more information on invasive cancer and survival refer to http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6409a1.htm?s_cid=mm6409a1_x

For current information on hereditary caner syndromes and risk assessment refer to Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1538-43.

For the National Institute for Health and Care Excellence guidelines for cancer recognition and referral go to http://www.nice.org.uk/guidance/NG12/chapter/1-recommendations.

For the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline refer to http://jco.ascopubs.org/content/early/2015/12/07/JCO.2015.64.3809.full

For current information on the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer, refer to The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Committee Opinion No. 659. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e93-6.

For recommendations regarding aromatase inhibitors in GYN practice, refer to Aromatase inhibitors in gynecologic practice. Committee Opinion No. 663. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e170-4.

For recommendations regarding benign breast disease, refer to Diagnosis and management of benign breast disorders. Practice Bulletin No. 164. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e141-56.

[D]

Dermatoses (Vol VI, No 3)

For current statistics regarding melanoma in the United States refer to http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a6.htm?s_cid=mm6421a6_x

[E]

Elder Abuse (Vol VIII, No 3)

For more information on elder abuse refer to: http://www.acog.org/Resources_And_Publications/Committee_Opinions
/Committee_on_Health_Care_for_Underserved_Women/Elder_Abuse_and_Womens_Health

Exercise (Vol XII, No 2)

For a resource from the CDC on CV disease prevention by exercise, refer to Omura JD, Carlson SA, Paul P, Watson KB, Loustalot F, Foltz JL, et al. Adults eligible for cardiovascular disease prevention counseling and participation in aerobic physical activity—United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:1047-51.

For new information regarding warnings and contraindications to exercise during pregnancy refer to Physical activity and exercise during pregnancy and the postpartum period. Committee Opinion No. 650. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e135-42.

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

[G]

Genetics: Counseling, Testing, and Diagnosis (Vol XV, No 2)

For information on counseling about genetic testing and communication of genetic test results, refer to Counseling about genetic testing and communication of genetic test results. Committee Opinion No. 693. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e96-101

For information on carrier screening for genetic conditions, refer to Carrier screening for genetic conditions. Committee Opinion No. 691. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e41-55

For information on carrier screening in the age of genomic medicine, refer to Carrier screening in the age of genomic medicine. Committee Opinion No. 690. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e35-40

For more information on microarrays and next-generation sequencing technology, refer to Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Committee Opinion No. 682. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e262-8.

For various resources on genetics and genomics compiled by the American College of Obstetrician and Gynecologist's Resource Center refer to: http://www.acog.org/About-ACOG/ACOG-Departments/Resource-Center/WEBTREATS-Genetics-Genomics

Below is the current list of genetics-related guidelines developed by the American College of Obstetricians and Gynecologists:

Genetics and Molecular Diagnostic Testing (Technology Assessment No. 11)

Screening for Fetal Aneuploidy (Practice Bulletin No. 163)

Prenatal Diagnostic Testing for Genetic Disorders (Practice Bulletin No. 162)

Hereditary Breast and Ovarian Cancer Syndrome (Practice Bulletin No. 103)

Lynch Syndrome (Practice Bulletin No. 147)

The Importance of Preconception Care in the Continuum of Women's Health Care (Committee Opinion No. 313)

Perinatal Risks Associated With Assisted Reproductive Technology (Committee Opinion No. 324)

Using Preimplantation Embryos for Research (Committee Opinion No. 347)

Direct-to-Consumer Marketing of Genetic Testing (Committee Opinion No. 409)

Ethical Issues in Genetic Testing (Committee Opinion No. 410)

Family History as a Risk Assessment Tool (Committee Opinion No. 478)

Pharmacogenetics (Committee Opinion No. 488)

Personalized Genomic Testing for Disease Risk (Committee Opinion No. 527)

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis (Committee Opinion No. 581)

Newborn Screening and the Role of the Obstetrician-Gynecologist (Committee Opinion No. 616)

Hereditary Cancer Syndromes and Risk Assessment (Committee Opinion No. 634)

Cell-free DNA Screening for Fetal Aneuploidy (Committee Opinion No. 640)

Identification and Referral of Maternal Genetic Conditions in Pregnancy (Committee Opinion No. 643)

[H]

Hormone Therapy and Alternative Therapies for Menopause (Vol XIV, No 4)

For information on pap test and mammography guidelines refer to: http://www.acog.org/About_ACOG/ACOG_Departments/Annual_Womens_Health_Care/ Your_Annual_Health_Care_Visit

For the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines refer to: http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437741.48606.98

For information on dietary reference intakes for calcium and vitamin D refer to: https://iom.nationalacademies.org/~/media/Files/ReportFiles/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin D and Calcium 2010 Report Brief.pdf

For a complete listing of the College's resources on menopause refer to http://www.acog.org/Womens-Health/Menopause

For a complete listing of the College's resources on hormone therapy refer to http://www.acog.org/Womens-Health/Hormone-Therapy

Hypertension (Vol XV, No 1)

For information on emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period, refer to Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Committee Opinion No. 692. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017:129:e90-5.

For 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) refer to: http://jama.jamanetwork.com/article.aspx?articleid=1791497

For information on hypertension-related mortality in the United States in 2000-2013 refer to http://www.cdc.gov/nchs/data/databriefs/db193.htm

For additional information on preeclampsia, refer to First-trimester risk assessment for early-onset preeclampsia. Committee Opinion No. 638. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e25-7.

For the AGOG Practice Advisory on Low-Dose Aspirin and Prevention of Preeclampsia, refer to http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/Practice-Advisory-Low-Dose-Aspirin-and-Prevention-of-Preeclampsia-Updated-Recommendations

[L]

Liver Disease: General Pathophysiology, Diagnosis, and Management (Vol XV, No 6)

Liver Disease: General Pathophysiology, Diagnosis, and Management, Supplement, Volume XV, Number 6, November 2016

Liver Disease: Reproductive Considerations (Vol XVI, No 1)

Below is the current list of guidelines developed by the American College of Obstetricians and Gynecologists that relate to various aspects of liver disease in reproductive-aged and postmenopausal women:

Nausea and vomiting of pregnancy. Practice Bulletin No. 153. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e12-24.

American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.

Viral hepatitis in pregnancy. ACOG Practice Bulletin No. 86. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:941-56.

Cervical cancer screening and prevention. Practice Bulletin No. 168. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e111-30.

Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:197-206.

Noncontraceptive uses of hormonal contraceptives. Practice Bulletin No. 110. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;115:206-18.

Management of menopausal symptoms. Practice Bulletin No. 141. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;123:202-16.

Osteoporosis. Practice Bulletin No. 129. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:718-34.

Lower Urinary Tract Disorders (Vol VII, No 4)

For information on evaluation of uncomplicated stress urinary incontinence in women before surgical treatment refer to: Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment. Committee Opinion No. 603. American College of Obstetricians and Gynecologists and American Urogynecologic Society.

For information on onabotulinumtoxinA and the bladder refer to: OnabotulinumtoxinA and the Bladder. Committee Opinion No. 604. American College of Obstetricians and Gynecologists and American Urogynecologic Society.

For the latest patient information regarding overactive bladder symptoms refer to http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm426099.htm

For clinical practice guidelines on urinary incontinence refer to Urinary incontinence in women. Practice Bulletin No. 155. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e66-81.

[M]

Metabolic Bone Disease (Vol XIV, No 2)

For a resource from the NIH on vitamin D supplementation refer to Fact Sheet for Health Professionals: Vitamin D

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

For recommendations regarding aromatase inhibitors in GYN practice, refer to Aromatase inhibitors in gynecologic practice. Committee Opinion No. 663. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e170-4.

Multiple Sclerosis (Vol IX, No 5)

For information on the McDonald criteria for diagnosing multiple sclerosis refer to the following: http://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles
/Brochures/Paper-TipSheet_-2010-Revisions-to-the-McDonald-Criteria-for-the-Diagnosis-of-MS.pdf

[N]

Nutrition (Vol XIII, No 3)

For information on listeria refer to: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Committee Opinion No. 614. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;124:1241-4.

For a resource from the NIH on vitamin D supplementation refer to Fact Sheet for Health Professionals: Vitamin D

For new information regarding warnings and contraindications to exercise during pregnancy refer to Physical activity and exercise during pregnancy and the postpartum period. Committee Opinion No. 650. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e135-42.

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

For information on seafood consumption during pregnancy, refer to the ACOG Practice Advisory: Update on Seafood Consumption During Pregnancy at http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/ACOG-Practice-Advisory-Seafood-Consumption-During-Pregnancy

[O]

Obesity (Vol XII, No 1)

For information on ethical issues in the care of the obese woman refer to: Ethical Issues in the Care of the Obese Woman. Committee Opinion No. 600. American College of Obstetricians and Gynecologists.

For The Obesity Society, American College of Cardiology, and American Heart Association guidelines on management of obesity, go to Guidelines (2013) for Managing Overweight and Obesity in Adults

For information regarding a treatment option for long-term weight management refer to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm

For information on gynecologic surgery in the obese woman refer to: Gynecologic surgery in the obese woman. Committee Opinion No. 619. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:274-8.

For new information on obesity in pregnancy refer to Obesity in pregnancy. Practice Bulletin No. 156. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e112-26.

For new information regarding warnings and contraindications to exercise during pregnancy refer to Physical activity and exercise during pregnancy and the postpartum period. Committee Opinion No. 650. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e135-42.

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

For current prepregnancy BMI data from the Centers for Disease Control and Prevention, refer to Prepregnancy Body Mass Index by Maternal Characteristics and State: Data From the Birth Certificate, 2014.

For a position statement on adolescent obesity from the Society for Adolescent Health and Medicine, refer to Society for Adolescent Health and Medicine. Preventing and treating adolescent obesity: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health 2016;59:602-6.

Occupational Diseases and Injuries (Vol IX, No 3)

For related information on exposure to toxic environmental agents refer to:

http://www.acog.org/Resources_And_Publications/Committee_Opinions
/Committee_on_Health_Care_for_Underserved_Women
/Exposure_to_Toxic_Environmental_Agents


http://www.acog.org/About_ACOG/ACOG_Departments/Health_Care_for_Underserved_
Women/~/media/Committee%20Opinions/Committee%20on%20Health%20Care%20for
%20Underserved%20Women/ExposuretoToxic.pdf

[P]

Polycystic Ovary Syndrome (Vol XV, No 4)

For the latest resources on evaluation, management, and health care needs, of patients with polycystic ovary syndrome, refer to the Centre for Research Excellence in Polycystic Ovary Syndrome.

Perioperative Considerations for Coexisting Medical Conditions (Vol IX, No 4)

For Practice Guidelines for Postanesthetic Care refer to: http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1918686

For 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines refer to: http://circ.ahajournals.org/content/early/2014/07/31/CIR.0000000000000106.full.pdf

For information on chronic antithrombotic therapy and gynecologic surgery refer to: http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Chronic-Antithrombotic-Therapy-and-Gynecologic-Surgery

[R]

Renal Disease (Vol X, No 1)

For Consumer fact sheet on screening for chronic renal disease from the U.S. Preventive Services Task Force refer to: http://www.uspreventiveservicestaskforce.org/uspstf12/kidney/ckdfact.pdf

[S]

Sexuality and Sexual Disorders (Vol XIII, No 2)

For information on testosterone therapy in female sexual dysfunction refer to: Androgen Therapy: A Reappraisal: An Endocrine Society Clinical Practice Guideline.

For a compilation of resources on sex and sexuality prepared by the ACOG Resource Center, refer to http://www.acog.org/About_ACOG/ACOG_Departments
/Resource_Center/WEBTREATS_Sex_and_Sexuality

Sleep Disorders (Vol XI, No 3)

For current patient information from the American Sleep Apnea Association, refer to http://sleepapnea.org/index.html

For information regarding a treatment option for insomnia refer to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409950.htm

[T]

Thyroid Disorders (Vol XII, No 5)

For information regarding thyroid disease in pregnancy refer to Thyroid disease in pregnancy. Practice Bulletin No. 148. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015; 125:996 -1005.

[U]

Upper Gastrointestinal Tract, Biliary, and Pancreatic Disorders (Vol XI, No 4)

For the National Institute for Health and Care Excellence guidelines for cancer recognition and referral go to http://www.nice.org.uk/guidance/NG12/chapter/1-recommendations.

 




Editor
Russell R. Snyder, MD

Associate Editor
Gretchen M. Lentz, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year